Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2009
10/28/2009EP1582582B1 Cell extract of escherichia coli having a mutation in the s12 ribosomal protein and process for producing proteins in cell-free systemes
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1453956B1 Method for large scale production of virus antigen
10/28/2009EP1430082B1 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
10/28/2009EP1421539B1 Stabilized factor viii with engineered disulfide bonds
10/28/2009EP1358322B1 A method of increasing complementarity in a heteroduplex polynucleotide
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009EP0787181B1 Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
10/28/2009CN101568647A Secretion of antibodies without signal peptides from bacteria
10/28/2009CN101565726A Process for preparing antibody for small molecular substance using nanoliposome immune adjuvant
10/28/2009CN101565714A Carbon resource-dependent genetic transformation system for trichoderma reesei and use thereof
10/28/2009CN101565690A Enrofloxacin monoclonal antibody and application
10/28/2009CN101565681A Mycoplasma hyopneumoniae P36 gene recombined Pichia pastoris and expression protein
10/28/2009CN101565680A Mycoplasma hyopneumoniae P97R1 gene recombined Pichia pastoris and expression protein
10/28/2009CN100554431C Method of producing protein
10/27/2009US7608704 Isolated polynucleotide encoding a polypeptide having preprosecretin activity and the amino acid sequence of SEQ ID NO:6; genetic engineering; cell cultures; antiproliferative agents; autoimmune diseases; antiinflammatory agents; cardiovascular/ nervous system/ developmental/gene expression disorders
10/27/2009US7608703 Nucleic acid with acyl transferase activity; vectors, host cells; biosynthesis of polyunsaturated fatty acid (PUFA)
10/27/2009US7608702 PUFA polyketide synthase systems and uses thereof
10/27/2009US7608700 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
10/27/2009US7608698 Muscular disorders; cardiovascular disorders; cell transformed with nucleic acid; culture product
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608695 Substance with antithrombotic activity and method for detecting glycokallidin
10/27/2009US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease
10/27/2009US7608686 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608450 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
10/27/2009US7608445 Increased activity and stability at increased pH and temperature
10/27/2009US7608437 Producing coryneform bacteria with an improved amino acid or nucleic acid productivity by introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of a coryneform bacterium so that it is close to a consensus sequence; high yields; producing L-glutamic acid
10/27/2009US7608431 High concentration, high average sialic acid content per EPO molecule
10/27/2009US7608430 Fusion protein; multimeric protein; treating interferon gamma -related conditions
10/27/2009US7608429 Methods and compositions for increasing antibody production
10/27/2009US7608428 Polynucleotide encoding an IL-28B polypeptide
10/27/2009US7608427 Encoding polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
10/27/2009US7608426 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair
10/27/2009US7608425 For increasing the longevity of a cell culture and permitting the increased production of recombinant proteins; culturing
10/27/2009US7608424 Process for production of a recombinant protein and a fusion protein
10/27/2009US7608423 Expanding the eukaryotic genetic code
10/27/2009US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009US7608409 Screening assay using G-protein coupled receptor protein OT7T175
10/27/2009US7608280 Method of producing FR901228
10/27/2009US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009US7608267 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608248 phenylalanine and tyrosin having a labeled pattern ( deuteration) which allows the chain-assignment of the signals originated from the main chain to extend even to the assignment of the ring portions; when determining protein structure by nuclear magnetic resonance, permits improvment in the sensitivity
10/27/2009CA2224143C Recombinant hexose oxidase, a method of producing same and use of such enzyme
10/27/2009CA2148492C Bovine heat shock promoter and uses thereof
10/22/2009WO2009129379A1 Methods for enhanced production of bone morphogenetic proteins
10/22/2009WO2009128448A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
10/22/2009WO2008115404A8 Treatment method using egfr antibodies and src inhibitors and related formulations
10/22/2009US20090265809 Modified Cry3A Toxins and Nucleic Acid Sequences Coding Therefor
10/22/2009US20090265797 Novel Anti-IGF-IR Antibodies and Uses Thereof
10/22/2009US20090264625 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
10/22/2009US20090264624 Human cytokine receptor
10/22/2009US20090264617 Method of producing fr901228
10/22/2009US20090264616 Cyclodipeptide Synthetases and Their Use for Synthesis of Cyclo(Leu-Leu) Cyclodipeptide
10/22/2009US20090264381 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264366 Transglutaminase Mediated Conjugation of Peptides
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264360 Cloning and expression of gonadotropin-releasing hormone (GnRH) receptors
10/22/2009US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264349 CD30 Ligand
10/22/2009US20090264343 Method of producing fr901228
10/22/2009US20090264311 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/22/2009US20090263866 Industrial-scale Serum-free Production of Recombinant Factor VII in Mammalian Cells
10/22/2009US20090263865 Substance Specific to Human PD-1
10/22/2009US20090263864 Recombinant production of mixtures of antibodies
10/22/2009US20090263863 Modification of protein glycosylation in methylotrophic yeast
10/22/2009US20090263862 Novel alkane polyol dehydrogenase
10/22/2009US20090263861 HOST-VECTOR SYSTEM ANTIBIOTIC-FREE ColE1 PLASMID PROPAGATION
10/22/2009US20090263860 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cell proliferative disorders
10/22/2009US20090263859 Thermophilic and thermoacidophilic glycosylation genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods
10/22/2009US20090263858 Process for synthesis of mucin-type peptides and muc1-related glycopeptides
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263429 Method of Preparing a Hydrogel
10/22/2009US20090263420 Virus-Like Particles As Vaccines For Paramyxovirus
10/22/2009US20090263412 Non-Splicing Variants of gp350/220
10/22/2009US20090263411 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263392 Methods of modifying antibodies for purification of bispecific antibodies
10/22/2009US20090263383 Antibodies to angiogenesis inhibiting domains of CD148
10/22/2009US20090263382 Stable and soluble antibodies inhibiting tnf alpha
10/22/2009US20090263376 Breaking immunological toterance with a genetically encoded unnatural amino acid
10/22/2009US20090263364 Method and constructs for delivering double stranded rna to pest organisms
10/22/2009US20090263351 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
10/22/2009US20090263348 Nucleic Acids Encoding Multimeric Fusion Proteins of TNF Superfamily Ligands
10/22/2009CA2720980A1 Methods for enhanced production of bone morphogenetic proteins
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2109682A2 Enhanced cell-free synthesis of active proteins containing disulfide bonds
10/21/2009EP2109673A2 Methods and compositions for enhanced protein expression and purification
10/21/2009EP1781802B1 Production of a tnfr-ig fusion protein
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1499885B1 Novel fusion proteins and assays for molecular binding
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1125